A review of HPV-related head and neck cancer

K Kobayashi, K Hisamatsu, N Suzui, A Hara… - Journal of clinical …, 2018 - mdpi.com
Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal lining of the
upper aerodigestive tract. Tobacco and alcohol use have been reported to be associated …

Epidemiology of head and neck cancer

EM Rettig, G D'Souza - Surgical oncology clinics, 2015 - surgonc.theclinics.com
Head and neck cancer (HNC) encompasses a heterogeneous group of upper aerodigestive
tract malignancies that together comprise the seventh most common cancer worldwide, 1 …

NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines

JJ Caudell, ML Gillison, E Maghami, S Spencer… - Journal of the National …, 2022 - jnccn.org
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …

Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists

JS Lewis Jr, B Beadle, JA Bishop… - … of pathology & …, 2018 - meridian.allenpress.com
Context Human papillomavirus (HPV) is a major cause of oropharyngeal squamous cell
carcinomas, and HPV (and/or surrogate marker p16) status has emerged as a prognostic …

NCCN guidelines insights: head and neck cancers, version 2.2017

D Adelstein, ML Gillison, DG Pfister, S Spencer… - Journal of the National …, 2017 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck
Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx …

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced …

R Haddad, A O'Neill, G Rabinowits, R Tishler… - The Lancet …, 2013 - thelancet.com
Background The relative efficacy of the addition of induction chemotherapy to
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …

Recent advances and future directions in clinical management of head and neck squamous cell carcinoma

J Muzaffar, S Bari, K Kirtane, CH Chung - Cancers, 2021 - mdpi.com
Simple Summary Even with recent advances, there are urgent needs for novel therapies to
improve overall survival and decrease toxicities in the management of head and neck …

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma

CH Chung, Q Zhang, CS Kong, J Harris… - Journal of clinical …, 2014 - ascopubs.org
Purpose Although p16 protein expression, a surrogate marker of oncogenic human
papillomavirus (HPV) infection, is recognized as a prognostic marker in oropharyngeal …

Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis

MA O'rorke, MV Ellison, LJ Murray, M Moran, J James… - Oral oncology, 2012 - Elsevier
Human Papillomavirus (HPV) related oropharyngeal squamous cell carcinomas (OPSCCs)
are reported to have improved prognosis and survival in comparison to other head and neck …

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer

C Fakhry, WH Westra, SJ Wang, A van Zante… - Cancer, 2017 - Wiley Online Library
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for
oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of women …